Alamar Biosciences, Inc. (ALMR) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $516.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-139.00K; Retained Earnings (Accumulated Deficit)USD $-203.30M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $12.11M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-80.00K; Retained Earnings (Accumulated Deficit)USD $-190.10M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in CapitalUSD $9.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-72.00K; Retained Earnings (Accumulated Deficit)USD $-168.78M.
- 2025-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD (m).
Alamar Biosciences, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.00K | $516.29M | $-139.00K | $-203.30M | $312.86M | $312.86M | 3 month · $3.18M |
| 2026-03-31 | $1.00K | $12.11M | $-80.00K | $-190.10M | $-178.07M | $-178.07M | 3 month · $1.45M |
| 2025-12-31 | $1.00K | $9.89M | $-72.00K | $-168.78M | $-158.95M | $-158.95M | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $-146.61M | 3 month · $680.00K |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $-140.29M | 3 month · $619.00K |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $-133.41M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |